Compare Garmin Ltd. (GRMN) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Garmin Ltd. vs Mesoblast Limited — how do they compare? Garmin Ltd. trades at $247.99 (market cap $46.62B), while Mesoblast Limited trades at $19.22 (market cap $2.31B). The key difference: Garmin Ltd. is far larger — about 20.2× Mesoblast Limited's market cap, and Garmin Ltd. pays a 1.74% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| GRMN | MESO | |
|---|---|---|
Market Cap | $46.62B | $2.31B |
Sector | Technology | Technology |
52-Week High | $267.52 | $20.96 |
52-Week Low | $187.10 | $11.35 |
Enterprise Value | $44.09B | $2.32B |
Dividend Yield | 1.74% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Garmin (GRMN) trades at $241.39, down 0.91% on the day, with a bullish technical signal supported by moving averages and a neutral RSI near 52. The stock shows strong fundamentals with 2025 revenue of $7.25B, net income margin of 23.26%, and consistent earnings beats in recent quarters. Recent product launches in aviation and marine electronics highlight innovation, while cash flow remains positive at $199.21M in 2025.
GRMN presents a solid investment case with robust profitability and growth, though valuation ratios like a P/E of 26.98 suggest premium pricing. Risks include competitive pressures and market volatility, but analyst consensus targets $281.50, indicating ~17% upside. The outlook is positive if earnings momentum continues, supported by dividend stability and institutional confidence.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Garmin Ltd.
Garmin produces GPS-enabled hardware and software for five verticals: fitness, outdoors, auto, aviation, and marine. The company relies on licensing mapping data to enable its hardware specialized for often niche activities like scuba diving or sailing. Garmin operates in 100 countries and sells its products via distributors as well as relationships with original equipment manufacturers.
Read more on GRMN →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
